Conversion to Belatacept Based Immunosuppression Regimen in Kidney Transplant Patients: Lessons Learned

被引:0
|
作者
Saidi, R. [1 ]
Huang, N. [1 ]
Yang, C. [1 ]
Movileanu, I. [1 ]
Ecal, K. [1 ]
Senay, A. [1 ]
Pankewycz, O. [1 ]
Dvorai, R. [1 ]
Shahbazov, R. [1 ]
Laftavi, M. [1 ]
机构
[1] SUNY Upstate, Syracuse, NY USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
277
引用
收藏
页码:432 / 432
页数:1
相关论文
共 50 条
  • [21] Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipients
    Launay, Manon
    Guitard, Joelle
    Dorent, Richard
    Prevot, Yoann
    Prion, Florent
    Beaumont, Laurence
    Kably, Benjamin
    Lecuyer, Lucien
    Billaud, Eliane M.
    Guillemain, Romain
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (02) : 553 - 563
  • [22] BELATACEPT BASED IMMUNOSUPPRESSION IN PATIENT WITH COMBINED HEART AND KIDNEY TRANSPLANT. A CASE REPORT
    Khan, Ayesha
    Elkarmi, Zaid
    Hussain, Syed
    Gamilla-Crudo, Ann Kathleem
    Mujtaba, Muhammad
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S116 - S116
  • [23] Infections in Kidney Transplant Recipients on Belatacept versus Tacrolimus-Based Immunosuppression.
    Gattis, S.
    Basu, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 933 - 934
  • [24] Long-Term Outcomes After Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant: A Matched Cohort Study.
    Divard, G.
    Debiais, C.
    Legendre, C.
    Aubert, O.
    Lefaucheur, C.
    Loupy, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 513 - 513
  • [25] Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients
    Gouin, Anna
    Sberro-Soussan, Rebecca
    Courivaud, Cecile
    Bertrand, Dominique
    Del Bello, Arnaud
    Darres, Amandine
    Ducloux, Didier
    Legendre, Christophe
    Kamar, Nassim
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (12): : 2195 - 2201
  • [26] Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Sethi, S.
    Choi, J.
    Vo, A.
    Peng, A.
    Lim, K.
    Najjar, R.
    Jordan, S.
    Huang, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 291 - 292
  • [27] BELATACEPT CONVERSION FOR LUNG TRANSPLANT RECIPIENT WITH KIDNEY DISEASE
    Kern, Christopher
    Doyle, Alden
    Weder, Max
    Floyd, Shawn
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 554 - 554
  • [28] Tacrolimus to belatacept conversion in proteinuric kidney transplant recipients
    Efe, Orhan
    Al Jurdi, Ayman
    Eiting, Morgan Mabey
    Marks, Christine Rogers
    Cote, Mariesa Ann
    Wojciechowski, David
    Safa, Kassem
    Gilligan, Hannah
    Azzi, Jamil
    Goyal, Nitender
    Raynaud, Marc
    Loupy, Alexandre
    Weins, Astrid
    Riella, Leonardo V.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Toxicity Driven Conversion to Belatacept in Kidney Transplant Recipients
    Cohen, E.
    Asch, W.
    Formica, R.
    Tichy, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [30] Infectious Complications After Belatacept Conversion in Kidney Transplant
    Marvin, J. E.
    Amenyedor, D.
    Azar, M. M.
    Belfield, K.
    Do, V.
    Formica, R.
    Cohen, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 370 - 370